Wealthspire Advisors (Maryland)’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Wealthspire Advisors (Maryland)'s BIIB Position: Q3 2020 in Review
Wealthspire Advisors (Maryland) reduced its Biogen (BIIB) stake by 31% in Q3 2020, selling an estimated $180K and leaving 1,440 shares worth $408K. The position accounts for 0.01% of the portfolio, ranked #307.
Wealthspire Advisors (Maryland) first reported a position in BIIB in Q4 2015 and has held it in 20 quarters since. The position peaked at $839K in Q4 2017. 1,051 funds tracked by Wall St. Rank hold BIIB as of Q3 2020.
- Wealthspire Advisors (Maryland) held 1,440 shares of Biogen worth $408K as of Q3 2020.
- Wealthspire Advisors (Maryland) sold 645 Biogen shares in Q3 2020, an estimated $180K.
- Biogen made up 0.01% of Wealthspire Advisors (Maryland)'s portfolio in Q3 2020, its #307 holding.
- Wealthspire Advisors (Maryland) first reported a position in Biogen in Q4 2015 and has held it in 20 quarters since.
- Wealthspire Advisors (Maryland)'s Biogen position peaked at $839K in Q4 2017.
- 1,051 funds tracked by Wall St. Rank held Biogen as of Q3 2020.
Based on Wealthspire Advisors (Maryland)'s 13F filing for Q3 2020, filed 13 Nov 2020.